Dopa as an antimetabolite in Huntington's disease.
D000215:Acylation; D000328:Adult; D000604:Amino Acyl-tRNA Synthetases; D000963:Antimetabolites; D001479:Basal Ganglia / Q000378:metabolism; D002421:Caudate Nucleus / Q000378:metabolism; D004295:Dihydroxyphenylalanine / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism; D006801:Humans; D006816:Huntington Disease / Q000201:enzymology / Q000209:etiology / Q000378:metabolism*; D008875:Middle Aged; D008968:Molecular Conformation; D009474:Neurons / Q000187:drug effects; D011506:Proteins / Q000378:metabolism; D012343:RNA, Transfer / Q000378:metabolism; D014443:Tyrosine / Q000037:antagonists & inhibitors / Q000378:metabolism; D014446:Tyrosine 3-Monooxygenase / Q000096:biosynthesis
D000963:Antimetabolites; D011506:Proteins; D014443:Tyrosine; D004295:Dihydroxyphenylalanine; D012343:RNA, Transfer; D014446:Tyrosine 3-Monooxygenase; D000604:Amino Acyl-tRNA Synthetases; D004298:Dopamine